PUBLISHER: GlobalData | PRODUCT CODE: 1366538
PUBLISHER: GlobalData | PRODUCT CODE: 1366538
Syringes, Needles, and Urinary Catheters Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2033 is built to visualize quantitative market trends within Hospital Supplies therapeutic area.
The model discusses the effect of COVID -19 on the Syringes, Needles, and Urinary Catheters market for the year 2020 and beyond. Syringe and Needles are devices used to inject fluids into or withdraw fluids from the body. A Syringe consist of a needle which is attached to a hollow tube with a sliding plunger that can help to intake or push down the fluid. Syringes and Needles are used for administration of several fluids and drawing fluids in the patients. Urinary catheters are used to treat patients with urinary incontinence, urinary retention, or other urological disorders. A urinary catheter is a flexible tube which is used to drain urine from the bladder. Urinary catheters include indwelling (Foley) catheter, intermittent (short term) catheter, and external (condom) catheter.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Syringes, Needles, and Urinary Catheters and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Becton Dickinson and Co, Equashield LLC, Avanos Medical Inc, Smiths Medical, Cardinal Health Inc, Novo Nordisk AS, Teleflex Inc, Coloplast Corp, Stryker Corp, Medline Industries Inc, Hollister Inc, Bioderm Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -